Catalyst Wire Dossier Catalyst Wire Dossier

91-day extended cycle oral contraceptive

· Teva Women's Health
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 91-day extended cycle oral contraceptive, covering 2014-08-29 to 2015-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women [Phase 2]

See pricing